Review article: Pathogenesis of the transformation from gastritis to malignancy

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue SUPPL. 1, 1998, Pages 61-71

  Sipponen, P ^a   Hyvarinen H ^a   Seppala K ^b   Blaser, M J ^c  

^a JORVI HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FREE RADICAL; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; NITRATE; NITRITE; SEX HORMONE;

ACHLORHYDRIA; ATROPHIC GASTRITIS; BACTERIAL OVERGROWTH; CHRONIC GASTRITIS; CONFERENCE PAPER; DISEASE COURSE; EPITHELIUM CELL; GENE MUTATION; GENOME; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTESTINE METAPLASIA; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REGULATOR GENE; SALT INTAKE; SMOKING; STOMACH CANCER; STOMACH PH; VITAMIN DEFICIENCY;

ANIMALS; FEMALE; GASTRITIS; GENES, P53; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0031904918     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1998.00005.x     Document Type: Review

References (86)

1. Schistosomes, liver flukes and Helicobacter pylori. In: IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, Volume 61. IARC, Lyon, France, 1994, pp. 177-220.
2. Sipponen P. Helicobacter pylori infection - a common worldwide environmental risk factor of gastric cancer? Endoscopy 1992; 24: 424-7.
3. Sipponen P, Kekki M, Siurala M. Precancerous conditions. In: Filipe MI, Jass JR eds. Gastric Cancer. Current Problems in Tumour Pathology. Churchill Livingstone, London, 1985: pp. 152-71.
4. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 265-72.
5. Dohi T, Hashiguchi M, Yamamoto S, Morita H, Oshima M. Fucosyltransferase-producing sialyl Le(a) and sialyl Le(x) carbohydrate antigen in benign and malignant gastrointestinal mucosa. Cancer 1994; 73: 1552-61.
6. Kobayashi K, Sakemoto J, Kito T, et al. Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am J Gastroenterol 1993; 88: 919-24.
7. Torrado J, Correa P, Ruiz B, Bernardi P, Zavala D, Bara J. Lewis antigen alterations in gastric cancer precursors. Gastroenterology 1992; 102: 424-30.
8. Torrado J, Correa P, Ruiz B, ZavalaD, Bara J. Prospective study of Lewis antigen alterations in the gastric precancerous process. Cancer Epidemiol Biomarkers Prev 1992; 1: 199-205.
9. Torrado J, Blasco E, Gutierrez-Hoyos A, Cosme A, Lojendio M, Arenas J I. Lewis system alterations in gastric carcinogenesis. Cancer 1990; 66: 1769-74.
10. Sipponen P, Äärynen M, Kääriäinen I, Kettunen P, Helske T, Seppälä K. Chronic antral gastritis, Lewis(a+) phenotype, and male sex as factors in predicting coexisting duodenal ulcer. Scand J Gastroenterol 1989; 24: 581-8.
11. Murata K, Egami H, Shibata Y, Sakamoto K, Misumi A, Ogawa M. Expression of bloodgroup-related antigens, ABH, Lewis(a), Lewis(b), Lewis(x), Lewis(y), Ca19-9, and CSLEX1 in early cancer, intestinal metaplasia, and uninvolved mucosa of the stomach. Am J Clin Pathol 1992; 98: 67-75.
12. Freston J W. Helicobacter pylori, acid, gastritis, atrophy and progression to cancer: a critical view. In: Hunt RH, Tytgat GNJ eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure 1996. Kluwer Academic Publishers, Boston, 1996: pp. 245-54.
13. Correa P. Human gastric carcinogenesis: a multistep and multi-factorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
14. Tahara E, Kuniyasu H, Yasui W, Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994; 6 (Suppl. 1): S97-S101.
15. Stolte M, Stadelmann O, Bethe B, Burkard G. Relationship between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. Z Gastroenterol 1995; 33: 89-93.
16. Altheron J, Cao P, Peek R M, Tummuru M K R, Blaser M J, Cover T C. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vagA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
17. Siurala M, Sipponen P, Kekki M. Chronic gastritis: dynamic and clinical aspects. Scand J Gastroenterol 1985; 20 (Suppl. 109): 69-76.
18. Kuipers E J, Uyterlinde A M, Pena A S, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 55: 2111-5.
19. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996, 31: 546-50.
20. Craanen M E, Dekker W, Blok P, Ferwerda J, Tytghat G N J. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16-20.
21. Correa P, Haenzel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 4737-40.
22. Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entities. Front Gastrointest Res 1980; 6: 98-108.
23. Kekki M, Sipponen P, Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scand J Gastroenterol 1984; 19: 382-8.
24. Hu P J, Li Y Y, Lin H L, et al. Gastric atrophy and regional variation in upper gastrointestinal disease. Am J Gastroenterol 1995; 90: 1102-6.
25. Kimura K. Chronologic transition of the fundic pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63: 584-92.
26. Kuipers E J, Perez-Perez G I, Meuwissen S G M, Blaser M J. Helicobacter pylori and atrophic gastritis: importance of cagA status. J Natl Cancer Inst 1995; 87: 1777-80.
27. Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes and Control 1993; 4: 297-305.
28. Cristofaro G, Lynch H T, Caruso M L. New phenotypic aspects in a family with Lynch syndrome II. Cancer 1987; 60: 51-58.
29. Varis K. A family study of chronic gastritis. Scand J Gastroenterol 1971; 6 (Suppl. 13): 1-50.
30. Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244-51.
31. Samloff I M, Varis K, Ihamäki T, Siurala M, Rotter J I. Relationship among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 82: 204-9.
32. Dixon M. Acid, ulcers, and H. pylori. Lancet 1993; ii: 384-5.
33. Lee A, Dixon M, Danon S J, et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-5.
34. Sipponen P, Kekki M, Seppälä K, Siurala M. The relationship between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther 1996; 10 (Suppl. 1): 103-18.
35. Sipponen P, Hyvärinen H, Siurala M. H. pylori corpus gastritis - relation to acid output. J Physiol Pharmacol 1996; 47: 151-9.
36. McColl K E L, Gillen D, El-Omar E, Oien K, Dahill S. Helicobacter pylori gastritis and gastric acid secretory function - an integrated approach. In: Hunt RH, Tytgat GNJ eds. Helicobacter pylori. Basic Mechanisms to Clinical Cure 1996. Kluwer Academic Publishers, Boston, 1996: 122-31.
37. Hansson L E, N'yren O, Hsing A W, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. Engl J Med 1996; 335: 242-9.
38. Lipkin M, Correa P, Mikol Y B, et al. Proliferative and antigenic modifications in human epithelial cells in chronic atrophic gastritis. J Natl Cancer Inst 1985; 75: 613-19.
39. Buset M, De Koster E, Deprez C, Nyst J F, Deltenre M, Brugmann G P. Gastric corpus cell cell proliferation, corpus gastritis and Helicobacter pylori. Proc Am Assoc Cancer Res 1992; 33: 38 (Abstract).
40. Cahill R J, Sant S, Hamilton H, Beattie S, O'Morain C. Helicobacter pylori and increased cell proliferation: a risk factor for cancer. Gastroenterology 1993; 104: A1032 (Abstract).
41. Fischbach W, Burkert M, Mössner J. Increased cell proliferation in Helicobacter pylori (HP) infection of human gastric mucosa. A flow cytometric study. Gastroenterology 1993; 104 (Suppl. 4): A78 (Abstract).
42. Lynch D A F, Axon A T R. Helicobacter pylori, gastric cancer and gastric epithelial kinetics: a review. Eur J Gastroenterol Hepatol 1995; 7 (Suppl. 1): S17-S23.
43. Slomiany B L, Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J Clin Gastroenterol 1992; 14 (Suppl. 1): S114-S121.
44. Wink D A, Kasprzak K S, Magaros K S, et al. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001-3.
45. Nguyen T, Brunson D, Crespi C L, Penman B W, Wishnok J S, Tannenbaum S R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natal Acad Sci USA 1992; 89: 3030-4.
46. Davis G R, Simmonds N J, Stevens T R J, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
47. Rautelin H, Blomberg B, Järneroth G, Danielsson G. Non-opsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers. Scand J Gastroenterol 1994; 29: 128-32.
48. Crabtree J E, Wyatt J I, Trejdosiewicz L K, et al. Interleukin 8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61-6.
49. Sharma S A, Tummuru M K R, Miller G G, Blaser M J. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infec Immun 1995; 63: 1681-7.
50. Cover T L, Cao P, lind C D, Tham K T, Blaser M J. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo. Infect Immun 1993; 61: 5008-12.
51. Blaser M J. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment Pharmacol Ther 1996; 10 (Suppl. 1): 73-7.
52. Fox J G, Correa P, Taylor N S, et al. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol 1992; 87: 1554-60.
53. Peek R M, Miller G G, Tham K T, et al. Heightened inflammatory response and cytokine expression to cagA+ Helicobacter pylori stains. Lab Invest 1995; 73: 760-70.
54. Peek R M, Moss S F, Tham K T, et al. Infection with H. pylori cagA+ strains dissociates gastric epithelial proliferation from apoptosis. J Natl Cancer Inst 1997; 89: 863-8.
55. Blaser M J, Pérez-Pérez G I, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cogA associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-15.
56. Genta R M. Helicobacter pylori as a promotor of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol 1995; 7 (Suppl. 1): S25-S30.
57. Stemmermann G N. Intestinal metaplasia of the stomach. A status report. Cancer 1994; 74: 556-64.
58. Lauwers G Y, Scott G V, Hendrichs J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994; 73: 2900-4.
59. Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-51.
60. Filipe I M, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 324-9.
61. Sipponen P, Seppälä K, Varis K, et al. Intestinal metaplasia with colonic type sulphomucins in the gastric mucosa. Acta Pathol Microbiol Scand, Section A, 1976; 23: 276-9.
62. Sugimura T, Matsukura N, Sato S. Intestinal metaplasia of the stomach as precancerous stage. In: Bartsch H, Armstron B, Davis W eds. Host factors in Human Carcinogenesis. IARC Scientific Publications no. 39, International Agency for Research on Cancer, Lyon, 1982: pp. 515-30.
63. Matsukura N, Kawachi T, Sugimura T, Nakadate M, Hirota T. Induction of intestinal metaplasia and carcinoma in the glandular stomach of rats by N-alkyl-N′-Nitro-N-Nitrosoguanidine. GANN 1979; 70: 181-5.
64. Sasajima K, Kawachi T, Matsukura N. Intestinal metaplasia and adenocarcinoma induced in the stomach of rats by N-propyl-N-Nitro-Nitrosoguanidine. Jpn Cancer Res Clin Oncol 1979; 94: 201-7.
65. Shimosato Y, Tanaka N, Kogure K, Fujimura S, Kawachi T, Sugimura T. Histopathology of tumors of canine alimentary tract produced by N-methyl-N′-nitro-N-nitrosoquanidine, with particular reference to gastric cancer. J Natl Cancer Inst 1971; 47: 1053-70.
66. Watanabe H. Experimentally induced intestinal metaplasia in Wistar rats by x-ray irradiation. Gastroenterology 1978; 75: 796-9.
67. Kigukawa K, Kato T, Takeda Y. Formation of highly mutagenic diazo compounds from bemethan-nitrate reaction. Mutat Res 1987; 177: 35-43.
68. Ohta T, Oribe H, Kamayama T, Goto Y, Takitani S. Formation of a diazoquinone-type mutahen from acetaminophen treated with nitrite under acidic conditions. Mutat Res 1988; 209: 95-8.
69. Oashima H, Friesen M, Malaveille C, Brouet I, Hautefeuille A, Bartsch H. Formation of direct-acting genotoxic substances in nitrosated smoked fish and meat products: identification of simple phenolic precursors and phenyldiazonium ions as reactive products. Food Chem Toxicol 1989; 27: 193-200.
70. Houghton P W J, Mortensen N J McC, Thomas W E G, Cooper M J, Morgan A P, Burton P. Intragastric bile acids and histological changes in gastric mucosa. Br J Surg 1986; 73: 354-6.
71. Sobala G M, Pignatelli B, Schorah C J, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acid is gastric juice in patients with and without precancerous conditions of the stomach. Carcinogenesis 1991; 12: 193-8.
72. Sobala G M, O'Connor H J, Dewar E P, King R F G, Axon A T R, Dixon M F. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993; 46: 235-40.
73. Taylor P R, Mason R C, Filipe M I, Vaja S, Hanleu D C, Murphy G M. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin immunohistochemistry, polyamine metabolism, and labelling index. Gut 1991; 32: 1447-54.
74. Sipponen P, Kekki M, Haapakoski J, Ihamäki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-7.
75. Kato I, Tominaga S, Ito Y, Kobayashi S, Yoshii Y, Matsuura A. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res 1992; 83: 1137-42.
76. Sipponen P, Riihelä M, Hyvärinen H, Seppälä K. Chronic non-atrophic ('superficial') gastritis increases the risk of gastric carcinoma. Scand J Gastroenterol 1994; 29: 336-40.
77. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49.
78. Siurala M, Varis K, Sipponen P. Carcinogenesis in the foregut: gastric carcinoma. In: Baron JH, Moody FG, eds. Foregut. Butterworths, London 1981: 276-312.
79. Perucho M. Microsatellite instability: the mutator that mutates the other mutator. Nature 1996; 2: 630-1.
80. Sano T, Tsujino T, Yoshikada K, et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17q in human gastric carcinomas. Cancer Res 1991; 51: 2926-31.
81. Tamura G, Kihana T, Nomura K, Terada M, Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-stranded corformation polymorphism analysis. Cancer Res 1991; 51: 3056-8.
82. Strickler J G, Zheng J, Shu Q, Burgart L J, Alberts S R, Shibata D. p53 mutations and microsatellite instability in sporadic gastric cancer: when quardians fail. Cancer Res 1994; 54: 4750-5.
83. Ranzani G N, Luinetti O, Padovan L S, et al. p53 mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol, Biomarkers & Prev 1995; 4: 223-31.
84. Rhyu M-G, Park W-S, Jung Y-J, Choi S-W, Meltzer S J. Allelic deletion of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 1994; 106: 1584-8.
85. Tahara E. Molecular biology of gastric cancer. World J Surg 1995; 19: 484-90.
86. Correa P, Shiao Y-H. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54: 1941s-1943s.